Scientists created a molecular switch that can revert the fate of cancer cells back to a normal state by capturing the moment of transition.

Researchers at the Cluster of Excellence Multiscale Bioimaging (MBExC) and the Else Kröner Fresenius Center for Optogenetic ...

A research team at the Politecnico di Milano has developed an innovative single-atom catalyst capable of selectively adapting ...

Researchers at the Cluster of Excellence Multiscale Bioimaging (MBExC) and the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ OT) of the University Medical Center Göttingen (UMG) have ...

A research team at the Politecnico di Milano has developed an innovative single-atom catalyst capable of selectively adapting its chemical activity. This is a crucial step forward in sustainable ...

The binding of proteins to DNA is crucial for producing other proteins, ensuring that all the necessary processes in cells ...

New study reveals how a DNA regulatory switch controls stem cell function, enabling the production of blood cells and ...

Discover how nanotechnology is advancing AI with energy-efficient chips, in-memory computing, neuromorphic hardware, and ...

On July 21, the United States Patent and Trademark Office (USPTO) accepted two patent applications from Dei BioPharma, a Ugandan biotechnology company led by Dr Matthias Magoola—a homegrown scientist ...

A new study led by Stephen D. Nimer, M.D., director of Sylvester Comprehensive Cancer Center, part of the University of Miami ...

Researchers have decoded the complete genome of Chionanthus retusus, a widely cultivated ornamental tree known for its ...

A study from the University of Groningen identified hundreds of RNA molecules that switch between shapes to regulate protein ...